Vera Therapeutics, Inc.
Therapeutic compounds for autoimmune kidney disease
- Sector
- Biotech
- Headquarters
- SOUTH SAN FRANCISCO, CA
- Founded
- 2016
- Latest Form D
- $70.7M, Feb 2021
- Total capital
- $70.7M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $70.7M
- 1 Form D · last Feb 2021
- 68 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 8 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$70.7M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Andrew ChengDirectorNamed in SEC Form D filings
- Beth SeidenbergDirectorNamed in SEC Form D filings
- Kurt von EmsterDirectorNamed in SEC Form D filings
- Maha KatabiDirectorNamed in SEC Form D filings
- Marshall FordyceExecutive Officer, DirectorNamed in SEC Form D filings
- Patrick EnrightDirectorNamed in SEC Form D filings
Show all 7 people
- Scott MorrisonDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 8- PendingMultispecific Antibody Molecules And Uses ThereofUSPTOApplication PCTUS2021063558
- PendingMultispecific Antibody Molecules And Uses ThereofUSPTOApplication 63126311
- PendingPna Oligomers And Related Methods Of Synthesis And Purification ThereofUSPTOApplication 62779224
Show all 8 patent records
- Multispecific Antibody Molecules And Uses ThereofApplication PCTUS2021063558Pending
- Multispecific Antibody Molecules And Uses ThereofApplication 63126311Pending
- Pna Oligomers And Related Methods Of Synthesis And Purification ThereofApplication 62779224Pending
- Lipid Nanoparticle Formulations Of Nucleic Acid MimicsApplication 62712162Pending
- Polymer-based Nanoparticles, Related Formulations Methods, And ApparatusApplication 62696791Pending
- Polymer-Based Nanoparticles Loaded With High Concentrations Of Biopolymers And Related Formulation Methods, Deformulation Methods and ApparatusApplication 62615389Pending
- Peptide Nucleic Acid (PNA) Monomers With An Orthogonally Protected Ester Moiety and Novel Intermediates and Methods Related TheretoApplication 62533582Pending
- Peptide Nucleic Acid (PNA) Monomers With An Orthogonally Protected Ester MoietyApplication 62475429Pending
Related companies, and why
- MYDNA, INCSimilar federal contract value in Biotech · null in contracts
- Nucleus Radiopharma, Inc.Similar federal contract value in Biotech · null in contracts
- TNF Pharmaceuticals, Inc.Similar federal contract value in Biotech · null in contracts
- Epicrispr Biotechnologies, Inc.Similar federal contract value in Biotech · null in contracts
- Elevation OncologySimilar federal contract value in Biotech · null in contracts
- NANOMATRONIX LLCSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .